Wells Fargo & Company »

Amylyx Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $504k 34k 14.72
2023-09-30 $830k 45k 18.31
2023-06-30 $1.2M 58k 21.57
2022-12-31 $64k 1.7k 36.95
2022-09-30 $27k 957 27.93
2022-06-30 $30k 1.6k 19.02
2022-03-31 $1.2M 90k 12.85